BORRELLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 581
EU - Europa 415
AS - Asia 83
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.080
Nazione #
US - Stati Uniti d'America 579
GB - Regno Unito 154
IE - Irlanda 78
CN - Cina 66
UA - Ucraina 47
SE - Svezia 44
DE - Germania 32
FR - Francia 19
FI - Finlandia 12
IT - Italia 12
TR - Turchia 10
ES - Italia 7
BE - Belgio 5
RU - Federazione Russa 3
SG - Singapore 3
CA - Canada 2
HU - Ungheria 2
AZ - Azerbaigian 1
EU - Europa 1
IR - Iran 1
KH - Cambogia 1
KR - Corea 1
Totale 1.080
Città #
Southend 133
Fairfield 103
Dublin 78
Ashburn 53
Woodbridge 49
Chandler 43
Jacksonville 40
Wilmington 39
Seattle 38
Cambridge 35
Houston 35
Ann Arbor 31
Nanjing 18
Princeton 15
Lancaster 13
Beijing 12
Dearborn 11
Izmir 9
Fremont 7
Málaga 7
Siena 7
Brussels 5
Helsinki 5
Boardman 4
San Diego 4
San Mateo 4
Shanghai 4
Hebei 3
Kunming 3
Moscow 3
Nanchang 3
Norwalk 3
Shenyang 3
Washington 3
Düsseldorf 2
Jiaxing 2
Jinan 2
New York 2
Ningbo 2
Pécs 2
Singapore 2
Toronto 2
Agliana 1
Changsha 1
Costa Mesa 1
Hangzhou 1
Lanzhou 1
London 1
Los Angeles 1
Munich 1
Nanning 1
Newark 1
Paris 1
Phnom Penh 1
Redwood City 1
Salerno 1
Shaoxing 1
Taizhou 1
Tianjin 1
Venezia 1
Totale 857
Nome #
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 201
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 163
Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D-3 and Serotonin 5-HT1A and 5-HT2A Receptors 155
Specific Targeting of Peripheral Serotonin 5-HT3 Receptors. Synthesis, Biological Investigation and Structure Activity Relationships. 128
Specific Targeting of Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. 2. Stereoselective Interaction to Overcome the Effects of Drug Resistant Mutations 124
Enantioselective binding of second generation pyrrolobenzoxazepinones to the catalytic ternary complex of HIV-1 RT wild-type and L100I and K103N drug resistant mutants 114
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition 114
Novel, Potent and Selective Quinoxaline-Based 5-HT3 Receptor Ligands. 1. Further Structure-activity Relationships and Pharmacological Characterization. 95
Totale 1.094
Categoria #
all - tutte 3.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020283 30 8 18 53 22 30 23 35 22 22 7 13
2020/2021181 12 15 8 14 13 37 4 26 19 10 13 10
2021/2022111 8 18 9 12 3 2 9 3 4 10 10 23
2022/2023146 7 14 22 17 17 27 3 11 15 9 1 3
2023/2024124 5 3 17 11 3 27 44 1 0 1 0 12
Totale 1.094